The company’s acquisition strategy is to act as a source of capital to these licensed medical-use cannabis growers by acquiring and leasing back their real estate locations. By selling the property and building to IIPR, and then leasing it back from the company, growers have the opportunity to redeploy the medical marijuana videos proceeds into their company’s core operation and yield a higher return than they would otherwise get from owning their own real estate. MyDx Inc. (OTCQB: MYDX) is a chemical detection and sensor technology company whose mission is to help people Trust & Verify what they put into their minds and bodies. The Company developed MyDx, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user’s hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology. The MyDx AquaDx, OrganaDx and CannaDx sensors are now commercialized, and the AeroDx application is next in line. All sensors will be compatible with a MyDx App that empowers consumers to live a healthier life by revealing the chemical composition of what they eat, drink and inhale. Canopy Growth Corporation (OTC: TWMJF) is a licensed producer of medical marijuana in Canada, Canopy Growth represented an ideal opportunity to conduct R&D and document the tangible benefits of its technology platform with cannabis.